119 related articles for article (PubMed ID: 19560596)
41. [Place of bacteriological examination in the treatment of tuberculosis].
Gyselen A
Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
[No Abstract] [Full Text] [Related]
42. Pyrazinamide-induced sideroblastic anemia.
Colucci G; Silzle T; Solenthaler M
Am J Hematol; 2012 Mar; 87(3):305. PubMed ID: 21818765
[No Abstract] [Full Text] [Related]
43. Ethambutol and capreomycin in the re-treatment of advanced pulmonary tuberculosis.
Lim BT; Aquinas M
Am Rev Respir Dis; 1969 May; 99(5):792-3. PubMed ID: 4977179
[No Abstract] [Full Text] [Related]
44. Treatment of extensively drug-resistant tuberculosis.
Aggarwal D; Mohapatra PR; Janmeja AK
Lancet; 2009 Jan; 373(9657):26-7; author reply 27-8. PubMed ID: 19121714
[No Abstract] [Full Text] [Related]
45. Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.
Johnson JL; Hadad DJ; Boom WH; Daley CL; Peloquin CA; Eisenach KD; Jankus DD; Debanne SM; Charlebois ED; Maciel E; Palaci M; Dietze R
Int J Tuberc Lung Dis; 2006 Jun; 10(6):605-12. PubMed ID: 16776446
[TBL] [Abstract][Full Text] [Related]
46. The pathogenicity of Mycobacterium tuberculosis during chemotherapy.
Clancy LJ; Kelly P; O'Reilly L; Byrne C; Costello E
Eur Respir J; 1990 Apr; 3(4):399-402. PubMed ID: 2114307
[TBL] [Abstract][Full Text] [Related]
47. [Ethambutol in the treatment of chronic pulmonary tuberculosis in patients excreting organisms resistant to several antitubercular agents].
Bek-Lissner E; Rózewska M
Gruzlica; 1971 Jul; 39(7):643-7. PubMed ID: 5000656
[No Abstract] [Full Text] [Related]
48. Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis.
Rosenthal IM; Williams K; Tyagi S; Vernon AA; Peloquin CA; Bishai WR; Grosset JH; Nuermberger EL
Am J Respir Crit Care Med; 2005 Dec; 172(11):1457-62. PubMed ID: 16141439
[TBL] [Abstract][Full Text] [Related]
49. [Test of short-term monotherapy in the clinical evaluation of the action of antitubercular agents].
Anastasatu C; Bercea O; Marcian S; Ceicu A
Arch Monaldi; 1971; 26(4):291-9. PubMed ID: 5004576
[No Abstract] [Full Text] [Related]
50. [Use of moxifloxacin in tuberculosis regimen in a French teaching hospital].
Berdot S; Papy E; Rioux C; Diamantis S; Ruimy R; Dombret MC; Arnaud P; Bouvet E
Med Mal Infect; 2010 Oct; 40(10):568-73. PubMed ID: 20554138
[TBL] [Abstract][Full Text] [Related]
51. Infectivity of sputum-positive tuberculous patients on chemotherapy.
Gunnels JJ; Bates JH; Swindoll H
Am Rev Respir Dis; 1974 Mar; 109(3):323-30. PubMed ID: 4205432
[No Abstract] [Full Text] [Related]
52. Hopkins scientist tunes in to treat tuberculosis.
Bloom S
J Clin Invest; 2005 Dec; 115(12):3302-3. PubMed ID: 16322772
[No Abstract] [Full Text] [Related]
53. Promising results for new tuberculosis therapy.
Bagchi S
CMAJ; 2008 Jan; 178(1):19. PubMed ID: 18166722
[No Abstract] [Full Text] [Related]
54. Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescent.
Hess S; Hospach T; Nossal R; Dannecker G; Magdorf K; Uhlemann F
Eur J Pediatr; 2011 Oct; 170(10):1337-42. PubMed ID: 21625932
[TBL] [Abstract][Full Text] [Related]
55. [Ethambutol in the treatment of pulmonary tuberculosis].
Bumbăcescu N; Ionescu C; Cărare A; Armaşu C; Vasiliu S; Popa N; Nicolae M; Tănase C
Ftiziologia; 1971; 20(4):381-6. PubMed ID: 5162275
[No Abstract] [Full Text] [Related]
56. Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model.
Nuermberger E; Tyagi S; Williams KN; Rosenthal I; Bishai WR; Grosset JH
Am J Respir Crit Care Med; 2005 Dec; 172(11):1452-6. PubMed ID: 16151038
[TBL] [Abstract][Full Text] [Related]
57. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
[TBL] [Abstract][Full Text] [Related]
58. A case of skin and lung tuberculosis: diagnostic difficulties.
Colasanti P; Cardone M; Zanchini R; Cordedda M; Grande A; Mozzillo R
G Ital Dermatol Venereol; 2013 Oct; 148(5):538-40. PubMed ID: 24005149
[No Abstract] [Full Text] [Related]
59. [Comparison of routine therapeutic protocols used in Madagascar for the treatment of smear-positive pulmonary tuberculosis (preliminary results)].
Boisier P; Rabarijaonal L; Rakotomanana F; Ratsitorahina M; Ratsirahonana O; Roux J; Auregan G
Arch Inst Pasteur Madagascar; 1995; 62(1):72-6. PubMed ID: 8638984
[TBL] [Abstract][Full Text] [Related]
60. [Comparative efficiency of treatment with moxyfloxacin and lomefloxacin for generalized murine tuberculosis caused by drug-resistant Mycobacterium strains].
Mozhokina GN; Sokolova GB; Dashieva DG; Mikhaĭlova LP; Elistratova NA
Probl Tuberk Bolezn Legk; 2005; (2):19-22. PubMed ID: 15881962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
